In June 2025, MBX Biosciences In announced it received preliminary feedback from the FDA on its planned Type B pre-IND meeting, supporting the advancement of its EL-22 program in combination with GLP-1 receptor agonists toward a Phase 2 clinical trial
[5] This means there is insufficient data to definitively establish safety profiles in this specific population
Cagrilintide is engineered to facilitate advanced studies into amylin receptor signaling, often researched for its potential impact on systemic metabolic regulation and appetite modulation
Recalculate your units
The isolated fraction induced delta-wave (slow-wave) sleep when injected into recipient animals giving the peptide its name and initiated one of the most distinctive research trajectories in neuropeptide biology: a compound with a clearly demonstrated biological name-property, an exceptionally wide pharmacological activity profile, and nearly five decades later a receptor that remains formally uncharacterised
Hasan M, Khatun A, Fukuta T, Kogure K
.png)
